Nordwand Advisors, LLC Merck & Co., Inc. Transaction History
Nordwand Advisors, LLC
- $374 Billion
- Q3 2024
A detailed history of Nordwand Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Nordwand Advisors, LLC holds 921 shares of MRK stock, worth $93,831. This represents 0.03% of its overall portfolio holdings.
Number of Shares
921
Previous 3,488
73.6%
Holding current value
$93,831
Previous $432 Million
75.78%
% of portfolio
0.03%
Previous 0.19%
Shares
6 transactions
Others Institutions Holding MRK
# of Institutions
3,808Shares Held
1.92BCall Options Held
13.4MPut Options Held
10.6M-
Vanguard Group Inc Valley Forge, PA245MShares$24.9 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$21.1 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$12 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.38 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$5.81 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $258B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...